Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1431 (LINC01431)

Target
LINC01431
Molecular classification
Long intergenic non-coding RNA, Long non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 1431 (LINC01431) is a long intergenic non-coding RNA gene that encodes a nuclear non-coding RNA molecule involved in the regulation of epigenetic cellular processes, particularly histone modification. LINC01431 does not code for a protein and functions through interactions with protein partners such as PRMT1, enhancing its stability and promoting histone H4 arginine 3 methylation (H4R3me2a), leading to transcriptional repression of hepatitis B virus (HBV) covalently closed circular DNA (cccDNA)[2][4]. LINC01431 activity impedes HBV replication and modulates the accessibility of viral DNA to transcriptional machinery. This lincRNA exemplifies a broader class of non-coding RNAs involved in fine-tuning gene expression and epigenetic landscapes, with emerging roles in infection and cancer biology[2][4][5]. Based on current literature and gene database entries, LINC01431 is not classified as a traditional therapeutic target (e.g., enzyme, receptor, transporter), and there are no validated drugs or direct clinical biomarkers associated with it[1][2][4].

Other names
LINC01431long intergenic non-protein coding RNA 1431
02

Mechanism of action

Not directly targeted by drugs but acts as a scaffold for regulating protein arginine methyltransferase 1 (PRMT1), affecting histone methylation and viral chromatin silencing[2][4].

03

Biological functions

Epigenetic regulationChromatin remodelingTranscriptional repression
04

Disease associations

Cancer (emerging evidence, context-dependent)Viral infection (notably Hepatitis B virus modulation)
05

Safety considerations

None reported as it is not currently directly targeted therapeutically

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1431 (LINC01431).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1431 (LINC01431).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call